<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biol Cell</journal-id><journal-id journal-id-type="pmc">boc</journal-id><journal-id journal-id-type="publisher-id">BoC</journal-id><journal-title-group><journal-title>Biology of the Cell</journal-title></journal-title-group><issn pub-type="ppub">0248-4900</issn><issn pub-type="epub">1768-322X</issn><publisher><publisher-name>Portland Press Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">boc1010695</article-id><article-id pub-id-type="doi">10.1042/BC20090060</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research article</subject></subj-group></article-categories><title-group><article-title>Integrin &#x003b1;8&#x003b2;1 regulates adhesion, migration and proliferation of human intestinal crypt cells via a predominant RhoA/ROCK-dependent mechanism</article-title><alt-title alt-title-type="right-running-head">&#x003b1;8&#x003b2;1 in intestinal progenitor cells</alt-title><alt-title alt-title-type="left-running-head">Y.D. Benoit and others</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Benoit</surname><given-names>Yannick&#x000a0;D.</given-names></name><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name><surname>Lussier</surname><given-names>Carine</given-names></name><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name><surname>Ducharme</surname><given-names>Pierre-Alexandre</given-names></name><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name><surname>Sivret</surname><given-names>Sophie</given-names></name><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name><surname>Schnapp</surname><given-names>Lynn&#x000a0;M.</given-names></name><xref ref-type="aff" rid="A2">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Basora</surname><given-names>Nuria</given-names></name><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name><surname>Beaulieu</surname><given-names>Jean-Fran&#x000e7;ois</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="corresp" rid="COR1"><sup>1</sup></xref></contrib><aff id="A1">*CIHR Team on the Digestive Epithelium, D&#x000e9;partement d'anatomie et biologie cellulaire, Facult&#x000e9; de m&#x000e9;decine et des sciences de la sant&#x000e9;, Universit&#x000e9; de Sherbrooke, Sherbrooke, QC, Canada, J1H 5N4</aff><aff id="A2">&#x02020;Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, WA 98104, U.S.A.</aff></contrib-group><author-notes><corresp id="COR1"><sup>1</sup>To whom correspondence should be addressed (email <email>Jean-Francois.Beaulieu@USherbrooke.ca</email>).</corresp></author-notes><pub-date pub-type="epreprint"><day>15</day><month>6</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>14</day><month>9</month><year>2009</year></pub-date><volume>101</volume><issue>Pt 12</issue><fpage>695</fpage><lpage>708</lpage><history><date date-type="received"><day>9</day><month>4</month><year>2009</year></date><date date-type="rev-recd"><day>8</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>15</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><italic>Background</italic>. Integrins are transmembrane &#x003b1;&#x003b2; heterodimer receptors that function as structural and functional bridges between the cytoskeleton and ECM (extracellular matrix) molecules. The RGD (arginine-glycine-aspartate tripeptide motif)-dependent integrin &#x003b1;8&#x003b2;1 has been shown to be involved in various cell functions in neuronal and mesenchymal-derived cell types. Its role in epithelial cells remains unknown.</p><p><italic>Results</italic>. Integrin &#x003b1;8&#x003b2;1 was found to be expressed in the crypt cell population of the human intestine but was absent from differentiating and mature epithelial cells of the villus. The function of &#x003b1;8&#x003b2;1 in epithelial crypt cells was investigated at the cellular level using normal HIECs (human intestinal epithelial cells). Specific knockdown of &#x003b1;8 subunit expression using an shRNA (small-hairpin RNA) approach showed that &#x003b1;8&#x003b2;1 plays important roles in RGD-dependent cell adhesion, migration and proliferation via a RhoA/ROCK (Rho-associated kinase)-dependent mechanism as demonstrated by active RhoA quantification and pharmacological inhibition of ROCK. Moreover, loss of &#x003b1;8&#x003b2;1, through RhoA/ROCK, impairs FA (focal adhesion) complex integrity as demonstrated by faulty vinculin recruitment.</p><p><italic>Conclusions</italic>. Integrin &#x003b1;8&#x003b2;1 is expressed in epithelial cells. In intestinal crypt cells, &#x003b1;8&#x003b2;1 is closely involved in the regulation of adhesion, migration and cell proliferation via a predominant RhoA/ROCK-dependent mechanism. These results suggest an important role for this integrin in intestinal crypt cell homoeostasis.</p></abstract><kwd-group kwd-group-type="kwd"><kwd>cell migration</kwd><kwd>cell proliferation</kwd><kwd>crypt cell</kwd><kwd>integrin</kwd><kwd>RhoA</kwd></kwd-group><kwd-group kwd-group-type="abbr"><kwd>BrdU, bromodeoxyuridine</kwd><kwd>Cdc42, cell division cycle 42</kwd><kwd>CNS, control non-silencing</kwd><kwd>DAPI, 4&#x02032;,6-diamidino-2-phenylindole</kwd><kwd>DPPIV, dipeptidyl peptidase IV</kwd><kwd>ECM, extracellular matrix</kwd><kwd>EV, empty vector</kwd><kwd>FA, focal adhesion</kwd><kwd>FX, focal complex</kwd><kwd>GST, glutathione transferase</kwd><kwd>HIEC, human intestinal epithelial (cells)</kwd><kwd>LSC, laser scanning cytometry</kwd><kwd>PFA, paraformaldehyde</kwd><kwd>RGD, arginine-glycine-aspartate tripeptide motif</kwd><kwd>RNAi, RNA interference</kwd><kwd>ROCK, Rho-associated kinase</kwd><kwd>RPLP0, ribosomal protein, large, P0</kwd><kwd>RT&#x02013;PCR, reverse transcription&#x02013;PCR</kwd><kwd>shRNA, small-hairpin RNA</kwd><kwd>TNfn3, third type-III fibronectin repeat of tenascin-C</kwd><kwd>TRITC, tetramethylrhodamine &#x003b2;-isothiocyanate</kwd><kwd>VSMC, vascular smooth muscle cell</kwd></kwd-group><counts><fig-count count="8"/><table-count count="1"/><ref-count count="67"/><page-count count="14"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Integrins are a superfamily of transmembrane receptors that form heterodimers of non-covalently associated &#x003b1;- and &#x003b2;-subunits. In mammals, more than 24 integrin receptors have been reported after the identification of 18 &#x003b1;- and nine &#x003b2;-subunits. Integrin receptors act as structural and functional bridges between the cytoskeleton and ECM (extracellular matrix) components and mediate intracellular signal transduction (Clark and Brugge, <xref ref-type="bibr" rid="B17">1995</xref>; Bershadsky et al., <xref ref-type="bibr" rid="B10">2006</xref>). Several integrins are present in epithelia throughout the organism, such as &#x003b1;1&#x003b2;1, &#x003b1;2&#x003b2;1, &#x003b1;3&#x003b2;1 and &#x003b1;6&#x003b2;4. The presence of these integrins at the surface of epithelial cells allows recognition and interaction with specific ligands including laminins, collagens and other glycoproteins (Mercurio, <xref ref-type="bibr" rid="B38">1995</xref>; Sheppard, <xref ref-type="bibr" rid="B48">1996</xref>; Beaulieu, <xref ref-type="bibr" rid="B5">1997</xref>). The integrin-dependent connection between the ECM and the cytoplasm promotes the regulation of cell functions such as adhesion, migration, proliferation, apoptosis and differentiation (Giancotti, <xref ref-type="bibr" rid="B27">1997</xref>; Reddig and Juliano, <xref ref-type="bibr" rid="B44">2005</xref>; Lock et al., <xref ref-type="bibr" rid="B32">2008</xref>).</p><p>The intestinal epithelium is a valuable system for understanding the relationship between cell state and interactions with the ECM. The functional unit of the small intestinal epithelium is organized as two distinct compartments, the crypts and villi, where proliferative and differentiated epithelial cell populations are located respectively (Arsenault and Menard, <xref ref-type="bibr" rid="B1">1989</xref>; M&#x000e9;nard and Beaulieu, <xref ref-type="bibr" rid="B36">1994</xref>; Babyatsky and Podolsky, <xref ref-type="bibr" rid="B2">1999</xref>). The crypt&#x02013;villus axis ensures the constant renewal of the epithelial barrier via a tight equilibrium between cell growth, migration and differentiation of mature enterocytes and apoptosis (Babyatsky and Podolsky, <xref ref-type="bibr" rid="B2">1999</xref>; M&#x000e9;nard et al., <xref ref-type="bibr" rid="B37">2006</xref>). In this context, these cell functions are susceptible to regulation by specific interactions between integrins and ECM components (Beaulieu, <xref ref-type="bibr" rid="B5">1997</xref>, <xref ref-type="bibr" rid="B7">1999</xref>; Zargham et al., <xref ref-type="bibr" rid="B64">2007a</xref>). Besides the laminin- and collagen-binding integrins common to most epithelial cells, intestinal epithelial cells have been found to express most other members of the &#x003b2;1 integrin repertoire at one time or another. For example, integrin &#x003b1;9&#x003b2;1, which can bind tenascin-C (Yokosaki et al., <xref ref-type="bibr" rid="B59">1998</xref>) and a cryptic domain of osteopontin (Smith et al., <xref ref-type="bibr" rid="B49">1996</xref>), is transiently expressed in epithelial cells of the intestinal crypts in an EGF (epidermal growth factor)-dependent manner (Desloges et al., <xref ref-type="bibr" rid="B19">1998</xref>) and is re-expressed in colon cancer cells (Basora et al., <xref ref-type="bibr" rid="B4">1997</xref>), whereas expression of the fibronectin receptor &#x003b1;5&#x003b2;1 and the &#x003b1;v-containing integrin(s) was found to be related to intestinal cell proliferation (Beaulieu et al., <xref ref-type="bibr" rid="B6">1992</xref>; Vachon et al., <xref ref-type="bibr" rid="B54">1995</xref>; Zhang et al., <xref ref-type="bibr" rid="B66">2003</xref>).</p><p>Integrin &#x003b1;8&#x003b2;1 was first identified in the chick neuronal system prior to the characterization of its human counterpart (Bossy et al., <xref ref-type="bibr" rid="B13">1991</xref>; Schnapp et al., <xref ref-type="bibr" rid="B46">1995a</xref>, <xref ref-type="bibr" rid="B47">1995b</xref>). So far, &#x003b1;8&#x003b2;1 has been shown to be associated with FA (focal adhesion) points where it participates in the regulation of spreading, adhesion, growth and survival in different neuronal and mesenchymal-derived cell types (Muller et al., <xref ref-type="bibr" rid="B39">1995</xref>; Schnapp et al., <xref ref-type="bibr" rid="B47">1995b</xref>; Levine et al., <xref ref-type="bibr" rid="B31">2000</xref>; Bieritz et al., <xref ref-type="bibr" rid="B11">2003</xref>; Wagner et al., <xref ref-type="bibr" rid="B56">2003</xref>; Farias et al., <xref ref-type="bibr" rid="B24">2005</xref>; Zargham and Thibault, <xref ref-type="bibr" rid="B62">2005</xref>; Zargham et al., <xref ref-type="bibr" rid="B64">2007a</xref>). Integrin &#x003b1;8&#x003b2;1 has been shown previously to modulate actin stress fibre assembly (Zargham and Thibault, <xref ref-type="bibr" rid="B63">2006</xref>) and to promote RhoA GTPase activation in VSMCs (vascular smooth muscle cells) (Zargham et al., <xref ref-type="bibr" rid="B64">2007a</xref>, <xref ref-type="bibr" rid="B65">2007b</xref>). However, the existence of an analogous mechanism in an epithelial context has not yet been reported.</p><p>In the present study, we report that &#x003b1;8&#x003b2;1 is expressed in the crypt cell population of the human small intestine where it represents one of the major RGD (arginine-glycine-aspartate tripeptide motif)-binding integrins and is a central RhoA/ROCK (Rho-associated kinase)-dependent modulator of cell migration and proliferation, two fundamental functions of intestinal crypt cells.</p></sec><sec sec-type="results"><title>Results</title><sec><title>Expression of the integrin &#x003b1;8 subunit in human intestinal epithelial cells</title><p>Previous analyses of gene expression profiles in intestinal cells failed to identify integrin subunits that displayed statistically significant levels of differential expression between proliferating and differentiating cells (Tremblay et al., <xref ref-type="bibr" rid="B51">2006</xref>). Rescreening of these experimental models by RT&#x02013;PCR (reverse transcription&#x02013;PCR) revealed &#x003b1;8 to be a strongly differentially expressed &#x003b1;-subunit. The &#x003b1;8-subunit was not expressed by differentiating villus-like Caco-2/15 cells but was present in undifferentiated crypt-like HIEC (human intestinal epithelial cells) at the transcript (<xref ref-type="fig" rid="F1">Figure 1</xref>A) and protein levels (<xref ref-type="fig" rid="F1">Figure 1</xref>B). To emphasize a potential relationship between &#x003b1;8&#x003b2;1 expression and the undifferentiated phenotype, we analysed &#x003b1;8 expression in HIEC cells overexpressing GATA-4, a transcription factor well known for its ability to trigger enterocytic differentiation. Induction of the differentiation marker DPPIV (dipeptidyl peptidase IV) in HIEC/GATA-4 cells was accompanied by a dramatic decrease in the &#x003b1;8 subunit level (<xref ref-type="fig" rid="F1">Figure 1</xref>C), suggesting that &#x003b1;8&#x003b2;1 integrin expression was restricted to undifferentiated progenitor epithelial cells. To further study this correlation, we analysed &#x003b1;8 subunit expression <italic>in vivo</italic> on 14- and 20-week human fetal jejunum specimens by indirect immunofluorescence. In 14-week specimens, the &#x003b1;8 subunit was detected at the base of the proliferative epithelial cells located in the intervillous area (<xref ref-type="fig" rid="F2">Figures 2</xref>A and <xref ref-type="fig" rid="F2">2</xref>C). At 20&#x000a0;weeks of gestation, the &#x003b1;8 subunit persisted at the base of the proliferative epithelial cell population located in the newly formed crypts, and strong expression of &#x003b1;8 was now also present in the stromal cell population (<xref ref-type="fig" rid="F2">Figures 2</xref>B and <xref ref-type="fig" rid="F2">2</xref>D). Integrin &#x003b1;8&#x003b2;1 expression in human fetal intestinal epithelial cells was further confirmed by RT&#x02013;PCR of pure epithelial and mesenchymal fractions isolated from 18&#x02013;20-week jejunum specimens. As expected, &#x003b1;8 mRNA was readily detected in the mesenchyme, as well as in the epithelial fraction (<xref ref-type="fig" rid="F2">Figure 2</xref>E). Fraction purity was verified by assessing the presence of specific markers for epithelium and mesenchyme, E-cadherin and vimentin respectively (<xref ref-type="fig" rid="F2">Figure 2</xref>E). Taken together, these results showed that integrin &#x003b1;8&#x003b2;1 was specifically expressed in intestinal crypt cells. We then investigated the role of this integrin using HIEC cells.</p><fig id="F1" position="float"><label>Figure 1</label><caption><title>Expression of the integrin &#x003b1;8 subunit in intestinal cells is lost with differentiation</title><p>(<bold>A</bold>) Representative RT&#x02013;PCR, indicating strong expression of the &#x003b1;8 subunit (Int &#x003b1;8) transcript in the progenitor HIEC cells and its absence in differentiating Caco-2/15 cells at various stages of confluence (0, +5 and +10&#x000a0;days post-confluence) as monitored by sucrase-isomaltase (SI) expression. (<bold>B</bold>) Confirmation of &#x003b1;8 expression in HIEC at the protein level was made by Westernblot analysis. (<bold>C</bold>) Representative RT&#x02013;PCR of &#x003b1;8 subunit transcript expression in stable HIEC cell lines with and without ectopic expression of GATA-4. RPLP0 was used as a normalizing gene and DPPIV as a differentiation marker.</p></caption><graphic xlink:href="boc517i001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Expression and distribution of the &#x003b1;8 integrin subunit in the human small intestine</title><p>Representative immunofluorescence micrographs of human jejunum cryosections at 14&#x000a0;weeks (<bold>A</bold>, <bold>C</bold>) and 20&#x000a0;weeks of gestation (<bold>B</bold>, <bold>D</bold>) stained with an anti-&#x003b1;8 integrin subunit antibody. In both stages, the &#x003b1;8 subunit was detected in the crypt regions (defined by the brackets in <bold>A</bold> and <bold>B</bold>). Higher magnifications of the crypt regions showed that the &#x003b1;8 subunit was present at the basolateral surface (arrows) of epithelial crypt cells (E) at both 14 and 20&#x000a0;weeks (<bold>C</bold>, <bold>D</bold>). Weak staining was observed in the mesenchyme (M) at 14&#x000a0;weeks, whereas at 20&#x000a0;weeks, specimens show more prominent staining with the differentiation of smooth muscle cells. Scale bars: (<bold>A</bold>, <bold>B</bold>) 50&#x000a0;&#x003bc;m and (<bold>C</bold>, <bold>D</bold>) 25&#x000a0;&#x003bc;m. (<bold>E</bold>) RT&#x02013;PCR experiments confirm the presence of the &#x003b1;8 transcript (Int &#x003b1;8) in the 18&#x02013;20&#x000a0;week jejunal epithelium accompanied by strong expression in the mesenchyme. Epithelial (E) and mesenchymal (M) fraction purity was validated by the absence of vimentin and E-cadherin (E-Cad) respectively.</p></caption><graphic xlink:href="boc517i002"/></fig></sec><sec><title>Impact of integrin &#x003b1;8&#x003b2;1 on RGD-dependent cell adhesion</title><p>Adhesion assays were performed on a GST (glutathione transferase) fusion peptide containing the TNfn3 (third type-III fibronectin repeat of tenascin-C), which possesses a functional RGD-binding domain for &#x003b1;8&#x003b2;1. Wild-type HIEC cells adhered efficiently to this RGD-containing domain (<xref ref-type="fig" rid="F3">Figure 3</xref>A), and adhesion was completely abolished in the presence of a soluble RGD-containing peptide (results not shown) or by blocking the &#x003b2;1 integrin subunit. The addition of a neutralizing anti-&#x003b1;v antibody reduced adhesion by approx. 50% and neutralizing antibodies directed against the &#x003b1;5 or &#x003b1;9 subunits did not significantly alter this RGD-dependent adhesion (<xref ref-type="fig" rid="F3">Figure 3</xref>A). By elimination, these results suggested the involvement of an additional RGD-dependent &#x003b2;1 integrin, such as &#x003b1;8&#x003b2;1, but we were unable to test this using this assay as no anti-&#x003b1;8 neutralizing antibody is yet available. We therefore opted for the establishment of &#x003b1;8-knockdown and CNS (control non-silencing) stable HIEC cell lines using shRNA (small-hairpin RNA) technology. By Western blotting, we confirmed that this strategy caused a &#x0223c;70% reduction in &#x003b1;8 subunit expression in HIEC/sh&#x003b1;8 compared with wild-type HIEC and HIEC/shCNS cells (<xref ref-type="fig" rid="F3">Figures 3</xref>B and <xref ref-type="fig" rid="F3">3</xref>C). In addition, we confirmed that the expression levels of integrin subunits &#x003b1;v and &#x003b2;1 in the three different cell lines were not affected (<xref ref-type="fig" rid="F3">Figures 3</xref>B and <xref ref-type="fig" rid="F3">3</xref>C). Using these shRNA cell lines we performed adhesion assays on the RGD-containing TNfn3 matrix, and showed a &#x0223c;70% decrease in the adhesion of HIEC/sh&#x003b1;8 cells compared with control HIEC/shCNS cells (<xref ref-type="fig" rid="F3">Figure 3</xref>D), confirming an important contribution of the &#x003b1;8&#x003b2;1 integrin to RGD-dependent adhesion of intestinal cells. Adhesion on the inactive RAA (arginine-alanine-alanine)-mutated TNfn3 matrix showed only negligible amounts of adherent cells, comparable with assays on control GST-coated plates, for both groups.</p><fig id="F3" position="float"><label>Figure 3</label><caption><title>Integrin &#x003b1;8&#x003b2;1 and RGD-dependent adhesion of human intestinal crypt cells</title><p>(<bold>A</bold>) Short-term (1&#x000a0;h) adhesion assays of HIEC cells plated on GST or RGD-containing GST&#x02013;TNfn3 coating. Cells were treated or untreated with neutralizing antibodies directed against RGD-binding integrins expressed by HIEC. Mouse IgG was used as a negative control (<italic>n</italic>&#x02265;3; *<italic>P</italic>&#x0003c;0.05; **<italic>P</italic>&#x0003c;0.01, compared with mouse IgG). (<bold>B</bold>) Assessment of &#x003b1;8 (Int &#x003b1;8), &#x003b1;v (Int &#x003b1;v) and &#x003b2;1 (Int &#x003b2;1) protein expression levels in wt (wild-type) HIEC and stable cell populations of HIEC/shCNS and HIEC/sh&#x003b1;8 by Western blotting. (<bold>C</bold>) Relative amounts of &#x003b1;8, &#x003b1;v and &#x003b2;1 were detected for each group according to the loading control keratin 18 (K18) (<italic>n</italic>=3; ***<italic>P</italic>&#x0003c;0.0001). (<bold>D</bold>) Long-term (24&#x000a0;h) adhesion assays with HIEC/shCNS and HIEC/sh&#x003b1;8 cells plated on GST, RGD-containing GST&#x02013;TNfn3 or RAA-mutated GST&#x02013;TNfn3 coating. Cycloheximide (10&#x000a0;&#x003bc;g/ml) was added to the adhesion medium to avoid endogenous fibronectin secretion/deposition (<italic>n</italic>=4; ***<italic>P</italic>&#x0003c;0.0001).</p></caption><graphic xlink:href="boc517i003"/></fig></sec><sec><title>Effect of &#x003b1;8 knockdown on focal contact and stress fibre organization</title><p>Since integrin &#x003b1;8&#x003b2;1 appeared to be important for the adhesion of epithelial crypt cells, we investigated the impact of &#x003b1;8&#x003b2;1 depletion on focal contact and actin cytoskeleton organization. Control and HIEC/sh&#x003b1;8 cells were seeded on serum-coated glass coverslips and analysed by double-labelling immunofluorescence using an anti-vinculin antibody to detect focal contacts and phalloidin to stain actin microfilaments. Knockdown of &#x003b1;8 expression in HIEC led to a reorganization of the actin network, from transverse and parallel stress fibres to a cortical localization (<xref ref-type="fig" rid="F4">Figures 4</xref>A and <xref ref-type="fig" rid="F4">4</xref>B). Moreover, we observed a significant decrease in the number of vinculin-positive FA points (<xref ref-type="fig" rid="F4">Figure 4</xref>C) and a reduction in spreading in HIEC/sh&#x003b1;8 cells, compared with control cells (<xref ref-type="fig" rid="F4">Figures 4</xref>A and <xref ref-type="fig" rid="F4">4</xref>B), without affecting the overall vinculin expression levels (<xref ref-type="fig" rid="F4">Figure 4</xref>D).</p><fig id="F4" position="float"><label>Figure 4</label><caption><title>Integrin &#x003b1;8&#x003b2;1 regulates focal contact and stress fibre organization</title><p>Representative micrographs of vinculin immunofluorescence (green) and TRITC&#x02013;phalloidin staining of actin stress fibres (red) on HIEC/shCNS (<bold>A</bold>) and HIEC/sh&#x003b1;8 (<bold>B</bold>) 24&#x000a0;h after seeding (<italic>n</italic>=4; scale bars: 50&#x000a0;&#x003bc;m). (<bold>C</bold>) Quantification of vinculin-stained FA per cell in HIEC/shCNS and HIEC/sh&#x003b1;8 (<italic>n</italic>=8; ***<italic>P</italic>&#x0003c;0.0001). (<bold>D</bold>) Vinculin expression levels in both cell populations were assayed by Western blot (<italic>n</italic>=3).</p></caption><graphic xlink:href="boc517i004"/></fig></sec><sec><title>Integrin &#x003b1;8&#x003b2;1 and RhoA GTPase activation</title><p>Considering the previously reported relationship between the integrin &#x003b1;8&#x003b2;1, actin network organization and small-GTPase RhoA membrane recruitment/activity (Zargham and Thibault, <xref ref-type="bibr" rid="B63">2006</xref>; Zargham et al., <xref ref-type="bibr" rid="B64">2007a</xref>, <xref ref-type="bibr" rid="B65">2007b</xref>), we treated HIEC cells with the Rho kinase (ROCK 1/2) pharmacological inhibitor Y-27632. ROCK is the principal effector of RhoA GTPase and, once activated, it contributes to cell growth, stress fibre assembly and recruitment of FA components (Loirand et al., <xref ref-type="bibr" rid="B33">2006</xref>). Treatment of wild-type HIEC with Y-27632 at 20&#x000a0;&#x003bc;M for 24&#x000a0;h (Lai et al., <xref ref-type="bibr" rid="B30">2003</xref>) generated a similar phenotype to the HIEC/sh&#x003b1;8 cells in terms of stress fibre assembly and vinculin distribution (<xref ref-type="fig" rid="F5">Figures 5</xref>A and <xref ref-type="fig" rid="F5">5</xref>B). We evaluated RhoA activity in HIEC/sh&#x003b1;8 cells by analysing the proportion of membrane-associated RhoA, which is indicative of the GTP-bound active conformation (Zargham et al., <xref ref-type="bibr" rid="B64">2007a</xref>). A significant decrease in membrane-associated RhoA was observed in HIEC/sh&#x003b1;8 compared with HIEC/shCNS cells, while the total amount of RhoA remained unchanged between the two groups (<xref ref-type="fig" rid="F5">Figure 5</xref>C and Supplementary Figure S1A at <ext-link ext-link-type="uri" xlink:href="http://www.biolcell.org/boc/101/boc1010695add.htm">http://www.biolcell.org/boc/101/boc1010695add.htm</ext-link>). We assayed RhoA activity directly by performing a RhoA&#x02013;GTP pull-down assay using beads coupled with the rhotekin RhoA-binding domain (Cetin et al., <xref ref-type="bibr" rid="B16">2007</xref>). HIEC/sh&#x003b1;8 cells demonstrated a significant reduction in the amount of active RhoA compared with HIEC/shCNS (<xref ref-type="fig" rid="F5">Figure 5</xref>D). No significant difference was observed in the total and membrane-associated amounts of Rac1 and Cdc42 (cell division cycle 42) GTPases in HIEC/shCNS and HIEC/sh&#x003b1;8 cells (Supplementary Figures S1B and S1C). These observations suggested that integrin &#x003b1;8&#x003b2;1 was central to RhoA functionality in intestinal undifferentiated epithelial cells.</p><fig id="F5" position="float"><label>Figure 5</label><caption><title>Integrin &#x003b1;8&#x003b2;1 and RhoA GTPase activation in HIEC</title><p>Representative micrograph of vinculin immunofluorescence (green) and TRITC&#x02013;phalloidin staining of actin stress fibres (red) in normal HIEC (<bold>A</bold>) and Y-27632-treated (20&#x000a0;&#x003bc;M) HIEC (<bold>B</bold>) over a 24&#x000a0;h period after seeding (<italic>n</italic>=3; scale bar: 50&#x000a0;&#x003bc;m). Western-blot analyses of RhoA in total and membrane fractionated protein extracts (<bold>C</bold>) from HIEC/shCNS and HIEC/sh&#x003b1;8 cells (<italic>n</italic>=3). (<bold>D</bold>) Active RhoA pull-down experiments using beads coupled with the rhotekin RhoA-binding domain with HIEC/shCNS and HIEC/sh&#x003b1;8 (<italic>n</italic>=4; **<italic>P</italic>=0.005). Int &#x003b2;1, integrin &#x003b2;1.</p></caption><graphic xlink:href="boc517i005"/></fig></sec><sec><title>Knockdown of the integrin &#x003b1;8 subunit affects vinculin, but not paxillin, recruitment to FAs</title><p>To further characterize the effect of &#x003b1;8 silencing on FA formation we plated control HIEC and HIEC/sh&#x003b1;8 on different substrata and quantified the number of vinculin- and paxillin-positive FAs that were generated (<xref ref-type="table" rid="T1">Table 1</xref> and Supplementary Figure S2 at <ext-link ext-link-type="uri" xlink:href="http://www.biolcell.org/boc/101/boc1010695add.htm">http://www.biolcell.org/boc/101/boc1010695add.htm</ext-link>). In wild-type HIEC and HIEC/shCNS cells plated on a serum coating, which provided the RGD-containing fibronectin and vitronectin, vinculin and paxillin displayed abundant (&#x0223c;70&#x02013;80 per cell) and broad (mature) FAs in a sparse peripheral pattern (<xref ref-type="table" rid="T1">Table 1</xref> and Supplementary Figures S2A and S2B). HIEC/sh&#x003b1;8 cells plated on a serum coating resulted in a severe decrease in the number of vinculin-positive FAs, whereas paxillin staining was not affected (<xref ref-type="table" rid="T1">Table 1</xref> and Supplementary Figure S2C). Similar observations were made for Y-27632-treated wild-type HIEC cells (<xref ref-type="table" rid="T1">Table 1</xref> and Supplementary Figure S2D), suggesting that recruitment of vinculin, but not paxillin, to the developing FA was RhoA/ROCK-dependent. Moreover, when HIEC/shCNS cells were seeded on a type-I collagen matrix, a non-RGD substratum, the number of vinculin-positive FAs was significantly reduced compared with paxillin-positive FAs (<xref ref-type="table" rid="T1">Table 1</xref> and Supplementary Figure S2E), closely recreating the phenotype of &#x003b1;8-knockdown and Y-27632-treated wild-type HIEC cells. To further document differences in cellular localization between vinculin and paxillin after &#x003b1;8 silencing, co-immunostaining was performed. Similar localization patterns of vinculin and paxillin were observed in the broad mature FAs at the periphery of control cells, with a few paxillin-positive punctate spots detected in the central region (<xref ref-type="fig" rid="F6">Figures 6</xref>A, <xref ref-type="fig" rid="F6">6</xref>C and <xref ref-type="fig" rid="F6">6</xref>E). HIEC/sh&#x003b1;8 cells displayed paxillin-stained dots localized more centrally that were apparently devoid of vinculin, whereas only 30% of paxillin-positive FAs were also vinculin-positive and were localized at the periphery of the cells (<xref ref-type="fig" rid="F6">Figures 6</xref>B, <xref ref-type="fig" rid="F6">6</xref>D and <xref ref-type="fig" rid="F6">6</xref>F).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><title>Quantification of vinculin- and paxillin-marked FAs</title><p>Results shown (means&#x000b1;S.E.M.) are the number of vinculin- and paxillin-positive FAs per cell in wild-type (wt), shCNS-, sh&#x003b1;8- and Y-27632-treated HIEC plated on to RGD-containing substratum and HIEC/shCNS on to type&#x000a0;I collagen (<italic>n</italic>&#x02265;8).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="5" rowspan="1">Number of FAs per cell</th></tr><tr><th rowspan="1" colspan="1"/><th colspan="4" rowspan="1">RGD-containing substratum</th><th rowspan="1" colspan="1">Collagen</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">HIEC/wt</th><th rowspan="1" colspan="1">HIEC/shCNS</th><th rowspan="1" colspan="1">HIEC/sh&#x003b1;8</th><th rowspan="1" colspan="1">HIEC/Y-27632</th><th rowspan="1" colspan="1">HIEC/shCNS</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Vinculin</td><td rowspan="1" colspan="1">70.83&#x000b1;2.24</td><td rowspan="1" colspan="1">78.90&#x000b1;9.76</td><td rowspan="1" colspan="1">20.33&#x000b1;1.19</td><td rowspan="1" colspan="1">15.13&#x000b1;1.11</td><td rowspan="1" colspan="1">18.63&#x000b1;2.00</td></tr><tr><td rowspan="1" colspan="1">Paxillin</td><td rowspan="1" colspan="1">69.75&#x000b1;5.89</td><td rowspan="1" colspan="1">73.88&#x000b1;4.38</td><td rowspan="1" colspan="1">77.25&#x000b1;6.84</td><td rowspan="1" colspan="1">73.38&#x000b1;12.27</td><td rowspan="1" colspan="1">76.00&#x000b1;7.45</td></tr></tbody></table></table-wrap><fig id="F6" position="float"><label>Figure 6</label><caption><title>Knockdown of the integrin &#x003b1;8 subunit affects vinculin localization but not paxillin in HIEC</title><p>(<bold>A</bold>&#x02014;<bold>D</bold>) Representative micrographs of vinculin (green) (<bold>A</bold>, <bold>B</bold>) and paxillin (red) (<bold>C</bold>, <bold>D</bold>) immunofluorescence detection in HIEC/shCNS (<bold>A</bold>, <bold>C</bold>) and HIEC/sh&#x003b1;8 cells (<bold>B</bold>, <bold>D</bold>) 24&#x000a0;h after seeding. (<bold>E</bold>, <bold>F</bold>) Merged images of vinculin and paxillin for HIEC/shCNS (<bold>E</bold>) and HIEC/sh&#x003b1;8 (<bold>F</bold>) illustrate the differential cellular localization of these two proteins under &#x003b1;8-knockdown conditions (<italic>n</italic>=3; scale bar: 25&#x000a0;&#x003bc;m).</p></caption><graphic xlink:href="boc517i006"/></fig></sec><sec><title>Reduced presence of integrin &#x003b1;8&#x003b2;1 up-regulates cell migration in the HIEC model</title><p>The functional role of RhoA in microfilament organization and its consequent impact on cell motility is well established. By performing wound assays (<xref ref-type="fig" rid="F7">Figure 7</xref>), we demonstrated a 40% increase in the amount of cells that migrated across the wound edge in HIEC/sh&#x003b1;8 cell monolayers compared with HIEC/shCNS cells. In these experiments, cell proliferation was blocked by the addition of 2&#x000a0;mM hydroxyurea to the incubation medium. Thus our results confirmed that &#x003b1;8 silencing led to the up-regulation of intestinal epithelial HIEC cell migration.</p><fig id="F7" position="float"><label>Figure 7</label><caption><title>Silencing of the &#x003b1;8 subunit increases migration in the HIEC cell line</title><p>Phase-contrast micrographs illustrating migrating HIEC/shCNS (<bold>A</bold>) and HIEC/sh&#x003b1;8 cells (<bold>B</bold>) across the wound edge after 48&#x000a0;h of incubation in the presence of 2&#x000a0;mM hydroxyurea (<italic>n</italic>=5; scale bar: 100&#x000a0;&#x003bc;m). (<bold>C</bold>) The histogram represents the number of cells that migrated across the wound edge (<italic>n</italic>=5; ***<italic>P</italic>&#x0003c;0.0001).</p></caption><graphic xlink:href="boc517i007"/></fig></sec><sec><title>Knockdown of the integrin &#x003b1;8 subunit impairs cell-cycle progression</title><p>Considering that the RhoA/ROCK pathway affects cell-cycle progression, we assessed the proliferation rate of HIEC/shCNS and HIEC/sh&#x003b1;8 cells by BrdU (bromodeoxyuridine) incorporation experiments. These experiments demonstrated a decrease of &#x0223c;50% in the number of BrdU-positive cells in HIEC/sh&#x003b1;8 cultures compared with control HIEC cells (<xref ref-type="fig" rid="F8">Figure 8</xref>A). Moreover, HIEC/shCNS cells treated with Y-27632 confirmed that ROCK inhibition in these control cultures resulted in a significant decrease in cell growth, comparable with that observed for &#x003b1;8-depleted cells (<xref ref-type="fig" rid="F8">Figure 8</xref>B). Importantly, the treatment of HIEC/sh&#x003b1;8 cells with Y-27632 had no additive effect on proliferation inhibition, suggesting that the integrin &#x003b1;8&#x003b2;1 stimulated proliferation via ROCK (<xref ref-type="fig" rid="F8">Figure 8</xref>B). HIEC &#x003b1;8-depleted cells also exhibited a corresponding significant decrease in cyclin D1 expression levels, but no significant changes were noted for p27<sup>Kip1</sup> (<xref ref-type="fig" rid="F8">Figure 8</xref>C), two cell-cycle regulators that have been reported to be potential downstream targets of the RhoA/ROCK pathway in various cell models (Croft and Olson, <xref ref-type="bibr" rid="B18">2006</xref>). LSC (laser scanning cytometry) analysis of HIEC/sh&#x003b1;8 and HIEC/shCNS populations showed that the decrease in cell growth found in HIEC/sh&#x003b1;8 cells was associated with a significantly higher percentage of cells in G<sub>1</sub> phase (<xref ref-type="fig" rid="F8">Figure 8</xref>D).</p><fig id="F8" position="float"><label>Figure 8</label><caption><title>Integrin &#x003b1;8&#x003b2;1 and cell-cycle progression in the HIEC cell lines</title><p>Histograms illustrating the percentage of BrdU-labelled cells for (<bold>A</bold>) HIEC/shCNS compared with HIEC/sh&#x003b1;8 and for (<bold>B</bold>) non-treated HIEC/shCNS compared with Y-27632-treated HIEC/shCNS and HIEC/sh&#x003b1;8 (***<italic>P</italic>&#x0003c;0.0005). (<bold>C</bold>) Quantification of the amounts of cyclin D1 and p27<sup>Kip1</sup> was performed in HIEC/shCNS and HIEC/sh&#x003b1;8. (i) Western-blot analysis; (ii) the relative amounts of cyclin D1 and p27<sup>Kip1</sup> detected for each group according to the loading control actin (<italic>n</italic>=3; *<italic>P</italic>=0.012). (<bold>D</bold>) Histogram illustrating the percentage of cells distributed in each of G<sub>1</sub>, S and G<sub>2</sub>+M cell-cycle phases for HIEC/shCNS and HIEC/sh&#x003b1;8 according to iCys LSC analysis (<italic>n</italic>=3; *<italic>P</italic>=0.015, ***<italic>P</italic>=0.0002).</p></caption><graphic xlink:href="boc517i008"/></fig></sec><sec><title>RNAi (RNA interference)-resistant &#x003b1;8 cDNA restores the wild-type phenotype in HIEC/sh&#x003b1;8 cells</title><p>To confirm that the observed cell adhesion and proliferation decreases, as well as the cell migration increase in HIEC, were due specifically to the depletion of &#x003b1;8&#x003b2;1 and not because of non-specific off-target effects of the RNAi pathway, we generated an &#x003b1;8 subunit &#x02018;rescue&#x02019; vector bearing three silent point mutations in the &#x003b1;8 cDNA that was resistant to RNAi-mediated knockdown. When HIEC/sh&#x003b1;8 cells were infected with the &#x003b1;8 subunit rescue lentivirus, the expression levels of the &#x003b1;8 subunit were restored (Supplementary Figure S3A at <ext-link ext-link-type="uri" xlink:href="http://www.biolcell.org/boc/101/boc1010695add.htm">http://www.biolcell.org/boc/101/boc1010695add.htm</ext-link>) and the cellular adhesion-, migration- and proliferation-related phenotypes were totally abolished and comparable with wild-type levels (Supplementary Figures S3B&#x02013;S3D). Taken together, these results show that the phenotypes induced by &#x003b1;8 shRNA are the result of specific depletion of the integrin &#x003b1;8 subunit.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In the present study, we report for the first time that the integrin &#x003b1;8&#x003b2;1 is expressed by epithelial cells. In the human small intestine, &#x003b1;8&#x003b2;1 was found to be restricted to the crypt cell population in the intact fetal intestine. Expression of &#x003b1;8&#x003b2;1 increases dramatically during development of the smooth musculature from 16&#x000a0;weeks onwards (Beaulieu et al., <xref ref-type="bibr" rid="B9">1993</xref>), including adult tissue (results not shown). Indeed, smooth muscle cells express high levels of &#x003b1;8&#x003b2;1 (Schnapp et al., <xref ref-type="bibr" rid="B46">1995a</xref>). Nevertheless, detection of the &#x003b1;8 transcript in purified epithelial fractions at mid-gestation, as well as in the crypt-like HIEC cells, confirmed the expression of &#x003b1;8&#x003b2;1 in epithelial crypt cells in the functional small intestine.</p><p>Additional experiments using HIEC cells revealed that the integrin &#x003b1;8&#x003b2;1 interacted in an RGD-dependent manner and promoted accurate FA and stress fibre assembly through RhoA activation, to enhance cell adhesion and proliferation, accompanied by a decrease in cell migration. Taken together, these findings suggest a role for &#x003b1;8&#x003b2;1 in the stimulation of proliferation while simultaneously restraining migration of these undifferentiated, progenitor epithelial cells towards the terminal differentiation compartment.</p><p>Integrin-dependent adhesion involves heterogeneous molecular complexes with the typical composition of anchor proteins such as vinculin and paxillin. The integrin&#x02013;matrix interactions are followed by the sequential formation of FXs (focal complexes), FAs and FBs (fibrillar adhesions), which leads to linkage of the actin network to the cell membrane (Zaidel-Bar et al., <xref ref-type="bibr" rid="B61">2004</xref>; Zimerman et al., <xref ref-type="bibr" rid="B67">2004</xref>). In adherent and spread cultured cells, stress fibres are associated with FAs and maintain an isometric actomyosin-based tension applied to the ECM (Geiger and Bershadsky, <xref ref-type="bibr" rid="B26">2001</xref>). The regulation of this phenomenon is primarily mediated through the small G-protein RhoA. The positive effect of the integrin &#x003b1;8&#x003b2;1 on the promotion of adhesion is not without precedent since other groups have reported that this RGD-dependent integrin is important for the spreading and generation of strong adhesive forces in mesangial, neuroendocrine, myofibroblastic cells and VSMCs, where interaction of &#x003b1;8&#x003b2;1 with the ECM led to cytoskeleton/FA assembly (Muller et al., <xref ref-type="bibr" rid="B39">1995</xref>; Lu et al., <xref ref-type="bibr" rid="B34">2002</xref>; Bieritz et al., <xref ref-type="bibr" rid="B11">2003</xref>; Zargham et al., <xref ref-type="bibr" rid="B65">2007b</xref>). In HIEC, reduction of adhesion in cells lacking &#x003b1;8 was accompanied by the decreased presence of vinculin in FAs and cortical rearrangement of the actin cytoskeleton. As a plausible explanation, it has been well documented that RhoA activity exerts a control on actin stress fibre assembly through the action of ROCK, the principal effector of this GTPase. This action contributes to decreased cell migration by enhancing adhesion on the ECM (Zaidel-Bar et al., <xref ref-type="bibr" rid="B60">2003</xref>; Cetin et al., <xref ref-type="bibr" rid="B15">2004</xref>; Russo et al., <xref ref-type="bibr" rid="B45">2005</xref>). As reported previously, &#x003b1;8&#x003b2;1 interacts either directly or indirectly with the GTPase RhoA, and facilitates RhoA recruitment to the plasma membrane, allowing its activation by membrane-bound associated proteins (Zargham et al., <xref ref-type="bibr" rid="B64">2007a</xref>). In further investigating this feature, we observed that HIEC &#x003b1;8-knockdown cells displayed a lower amount of RhoA in membrane protein extracts than in control HIEC, while membrane-associated levels of other GTPases such as Rac1 and Cdc42 remained constant. Moreover, pull-down experiments of the RhoA active form revealed a decrease of this activated GTPase in &#x003b1;8-knockdown HIEC cells. These findings suggest that the absence of integrin &#x003b1;8&#x003b2;1 in intestinal epithelial cells impairs the recruitment of RhoA to the membrane and, consequently, its activation.</p><p>As stated above, we observed that HIEC &#x003b1;8-knockdown cells displayed a reduced presence of vinculin at the FA, compared with wild-type HIEC, without affecting the expression level of this protein. In contrast, we observed no substantial change in the localization of paxillin, another well-characterized FA component (Turner, <xref ref-type="bibr" rid="B52">2000</xref>), suggesting that &#x003b1;8&#x003b2;1 contribution to FA assembly was specific to vinculin recruitment. Similar observations were made when the control HIEC were grown on the non-RGD substratum collagen I. These observations indicated that vinculin recruitment, but not paxillin, depends on the RGD cell&#x02013;matrix interaction system through integrin &#x003b1;8&#x003b2;1. Based on the proposed scheme of temporal stages in the formation and organization of cell&#x02013;matrix adhesions (Zaidel-Bar et al., <xref ref-type="bibr" rid="B61">2004</xref>), vinculin recruitment occurs during the late FX stage, while paxillin is already present in early FX. Thus our results suggest that the knockdown of &#x003b1;8 in HIEC impaired the maturation of focal contacts at the late FX stage.</p><p>Other groups have proposed that RhoA activity is involved in the recruitment of some FA components including vinculin (Barry and Critchley, <xref ref-type="bibr" rid="B3">1994</xref>; Zaidel-Bar et al., <xref ref-type="bibr" rid="B60">2003</xref>). Thus our findings strongly suggest that &#x003b1;8&#x003b2;1 is involved, through RhoA activity, in the recruitment of vinculin specifically to the developing focal contacts in intestinal epithelial cells. To emphasize the association between integrin &#x003b1;8&#x003b2;1 and RhoA GTPase in intestinal cells, we have shown that the inhibition of ROCK signalling led to a phenotype similar to that of the &#x003b1;8 knockdown in terms of both actin stress fibre organization and vinculin/paxillin distribution. This supports the hypothesis that the cytoskeleton rearrangement and FA aberrations observed in &#x003b1;8-knockdown cells are mediated largely by the RhoA/ROCK pathway. We also show that loss of &#x003b1;8 is associated with a decrease in cell proliferation, via a RhoA/ROCK mechanism. This signalling pathway has been identified as a modulator of cell-cycle progression through molecular events by which RhoA/ROCK/LIMK (LIM domain kinase) inhibition led to stress fibre disassembly, a decrease in ERK1/2 (extracellular-signal-regulated kinase 1/2) phosphorylation and subsequent cyclin D inhibition (Walker and Assoian, <xref ref-type="bibr" rid="B57">2005</xref>).</p><p>Furthermore, Croft and Olson showed that RhoA/ROCK activation led to down-regulation of p27<sup>Kip1</sup> and cyclin D1 up-regulation via independent mechanisms (Croft and Olson, <xref ref-type="bibr" rid="B18">2006</xref>). In HIEC cells, the observed antiproliferative effect of &#x003b1;8 knockdown was accompanied by a decrease in cyclin D1 expression, whereas the expression of the CDK (cyclin-dependent kinase) inhibitor p27<sup>Kip1</sup> was not affected. In agreement with these findings, the analysis of cell-cycle progression in &#x003b1;8-depleted cells has shown that a significantly higher percentage of the population accumulated in G<sub>1</sub> phase when compared with control HIEC. Thus cell-cycle progression analysis indicated that integrin &#x003b1;8&#x003b2;1 facilitated the progression from G<sub>1</sub> to S-phase in epithelial progenitor cells of the human intestine. Moreover, inhibition of ROCK in HIEC cells also resulted in a reduction in the amount of proliferative cells compared with &#x003b1;8-knockdown HIEC, suggesting that the &#x003b1;8&#x003b2;1-dependent mechanism of proliferation control acted mainly via RhoA/ROCK signalling.</p><p>In addition, we have shown that forced expression of GATA-4, a key transcription factor involved in enterocyte differentiation (Escaffit et al., <xref ref-type="bibr" rid="B21">2005a</xref>; Bosse et al., <xref ref-type="bibr" rid="B12">2007</xref>), led to markedly reduced &#x003b1;8 expression in the HIEC cell model. Mapping of the <italic>ITGA8</italic> (integrin &#x003b1;8) human promoter led to the identification of six putative GATA-binding sites in the 2800&#x000a0;bp upstream of the transcription initiation site (results not shown), which could mediate integrin &#x003b1;8 subunit transcriptional repression. These findings are in accordance with the fact that differentiated epithelial cells lack integrin &#x003b1;8&#x003b2;1 (the present study) and that RhoA activity is down-regulated during the intestinal epithelial differentiation process (Gout et al., <xref ref-type="bibr" rid="B28">2001</xref>). Also, our observations regarding &#x003b1;8&#x003b2;1 localization in the crypt&#x02013;villus axis and the regulation of cell-cycle progression via &#x003b1;8&#x003b2;1/RhoA are concordant with the inhibition of RhoA activity that normally occurs in the differentiating intestinal epithelium, where proliferative cells have to stop cycling prior to terminal differentiation (Pageot et al., <xref ref-type="bibr" rid="B40">2000</xref>). Thus the striking adhesion decrease, due to the loss of &#x003b1;8 expression, could be indicative of an induction of cell migration that occurs normally in the crypt&#x02013;villus axis after the triggering of the differentiation process in intestinal epithelial cells (Beaulieu, <xref ref-type="bibr" rid="B7">1999</xref>; Jobin et al., <xref ref-type="bibr" rid="B29">1999</xref>; Lussier et al., <xref ref-type="bibr" rid="B35">2000</xref>). As expected, wound assays revealed that the absence of &#x003b1;8&#x003b2;1 led to an increase in cell migration. Considering the antimigratory phenotype resulting from activation of RhoA GTPase in intestinal epithelial cells (Cetin et al., <xref ref-type="bibr" rid="B15">2004</xref>, <xref ref-type="bibr" rid="B16">2007</xref>), our results reinforce RhoA's status as a key element of the intracellular mechanism underlying integrin &#x003b1;8&#x003b2;1 activation.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Tissues</title><p>Specimens of small intestine (jejunum) from fetuses ranging in age from 14 to 20&#x000a0;weeks (post-fertilization) were obtained after legal abortion. The project was performed in accordance with protocols approved by the Institutional Human Research Review Committee of the Universit&#x000e9; de Sherbrooke for the use of human material. In some experiments, preparations of pure epithelial and mesenchymal fractions were prepared and analysed as previously described (Perreault et al., <xref ref-type="bibr" rid="B42">1998</xref>).</p></sec><sec><title>Cell culture</title><p>The HIEC cell line was generated and grown as previously described (Perreault and Beaulieu, <xref ref-type="bibr" rid="B41">1996</xref>). These cells express a number of crypt markers and are thus considered to be non-differentiated crypt-like progenitor cells (Quaroni and Beaulieu, <xref ref-type="bibr" rid="B43">1997</xref>; Pageot et al., <xref ref-type="bibr" rid="B40">2000</xref>; Escaffit et al., <xref ref-type="bibr" rid="B22">2005b</xref>; Tremblay et al., <xref ref-type="bibr" rid="B51">2006</xref>). The Caco-2/15 cell line has been generated and characterized previously for its ability to morphologically and functionally differentiate like villus small intestinal cells (Beaulieu and Quaroni, <xref ref-type="bibr" rid="B8">1991</xref>; Vachon and Beaulieu, <xref ref-type="bibr" rid="B53">1992</xref>; Tremblay et al., <xref ref-type="bibr" rid="B51">2006</xref>).</p></sec><sec><title>Establishment of &#x003b1;8-knockdown HIEC cells and GATA-4-expressing HIEC cells</title><p>Stable shRNA &#x003b1;8 subunit knockdown and CNS (shCNS) HIEC cell populations were established by lentiviral infection. The same strategy was used to generate a stable GATA-4-expressing HIEC cell population. The oligonucleotides used to generate sh&#x003b1;8 (5&#x02032;-GATCCGATCAGAGTTAATGGAACCTTCAAAGAGAGGTTCCATTAACTCTGATCTTTTTTGGAAC-3&#x02032; and complement 5&#x02032;-TCGAGTTCCAAAAAAGATCAGAGTTAATGGAACCTCTCTTGAAGGTTCCATTAACTCTGATCG-3&#x02032;), shCNS (5&#x02032;-GATCGTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACGTT-CGGAGAATTTTTTGGAAC-3&#x02032; and complement 5&#x02032;-TCGAGTTCCAAAAAATTCTCCGAACGTGTCACGTTCTCTTGAAACGTGACACGTTCGGAGAAC-3&#x02032;) and full-length &#x003b1;8 (5&#x02032;-CGATAAGCTTCTCCTTCCAG-3&#x02032;and complement 5&#x02032;-AACATCTGATACGACAACGG-3&#x02032;) were synthesized by IDT (Coralville, IA, U.S.A.). Silent mutations resistant to &#x003b1;8 shRNA were introduced into full-length human &#x003b1;8 subunit cDNA by PCR mutagenesis. Specifically, nucleotide residues 357 (C&#x02192;T), 358 (A&#x02192;C) and 360 (A&#x02192;T) from the <italic>ITGA8</italic> coding sequence (GenBank&#x000ae; accession number NM_003638) were substituted to generate the <sup>355</sup>atTCgTgttaatggaacc<sup>372</sup> mutant. The oligonucleotide annealed products were subcloned into pLVX-puro (Clontech, CA, U.S.A.). pLPCX/hGATA-4, pLPCX/EV, pLVX/&#x003b1;8-rescue, pLENTIU6/sh&#x003b1;8 and pLENTIU6/shCNS vectors (where EV is empty vector) were used to produce viruses in HEK-293T cells [human embryonic kidney cells expressing the large T-antigen of SV40 (simian virus 40)] as previously described (Boudreau et al., <xref ref-type="bibr" rid="B14">2007</xref>). Subconfluent HIEC cells were infected with viral suspensions containing 4&#x000a0;&#x003bc;g/ml polybrene (Sigma&#x02013;Aldrich) for 48&#x000a0;h at 37&#x000b0;C. The sh&#x003b1;8- and shCNS-infected cells were then selected for 10&#x000a0;days with 5&#x000a0;&#x003bc;g/&#x003bc;l blasticidin, while pLPCX/EV- and pLPCX/GATA-4-infected cells were selected for 10&#x000a0;days with 1&#x000a0;&#x003bc;g/&#x003bc;l puromycin to generate stable cell populations. GATA-4- and EV-infected cells were grown as described above for HIEC for 30&#x000a0;days and RNA was extracted for subsequent RT&#x02013;PCR analysis.</p></sec><sec><title>Generation of recombinant tenascin-C peptides: TNfn3 RGD and RAA</title><p>cDNA encoding recombinant tenascin-C fragments containing the third fibronectin type-III repeat with the intact RGD motif (TNfn3 RGD) and the mutated site (TNfn3 RAA) were generated by the method of Yokosaki et al (<xref ref-type="bibr" rid="B59">1998</xref>).</p></sec><sec><title>Antibodies and reagents</title><p>The rabbit polyclonal antibody targeting the human &#x003b1;8 cytoplasmic domain (Schnapp et al., <xref ref-type="bibr" rid="B47">1995b</xref>) was used at a 1:500 dilution for indirect immunofluorescence experiments. A rabbit anti-(chick &#x003b1;8) serum (a gift from Dr Louis F. Reichardt, Department of Physiology, University of California San Francisco, San Francisco, CA, U.S.A.) was also used at a 1:100 dilution in initial immunofluorescence experiments (data not shown). Antiserum directed against the &#x003b1;8 integrin subunit was kindly provided by Dr Ga&#x000e9;tan Thibault (IRCM, Montreal, QC, Canada) (Zargham and Thibault, <xref ref-type="bibr" rid="B62">2005</xref>), and used at 1:3000 for Western-blot experiments. Other antibodies used for Western blot were polyclonal anti-&#x003b1;v (AV1; 1:1000 dilution; Chemicon), anti-cyclin D1/D2 (1:5000; Santa Cruz Biotechnology), anti-p27<sup>Kip1</sup> (1:1000; Santa Cruz Biotechnology), anti-Cdc42 (1:500; Santa Cruz Biotechnology), monoclonal anti-cytokeratin 18 (CY-90; 1:10000; Sigma), anti-vinculin (7F9; 1:10000; Chemicon), anti-RhoA (26C4; 1:200; Santa Cruz Biotechnology), anti-Rac1 (1:1000; BD Transduction Laboratories), anti-&#x003b2;1 integrin [mAb13; 1:1000; a gift from Dr Kenneth M. Yamada, NIH (National Institutes of Health)/NIDCR (National Institute of Dental and Craniofacial Research), Bethesda, MD, U.S.A. (Fogerty et al., <xref ref-type="bibr" rid="B25">1990</xref>)], and anti-actin (C4; 1:75000; Chemicon) antibodies. For immunolocalization, we used the monoclonal antibodies anti-vinculin (7F9; 1:500; Chemicon) and anti-paxillin (1:500; BD Transduction Laboratories). For vinculin/paxillin co-immunolocalization, TRITC (tetramethylrhodamine &#x003b2;-isothiocyanate)-conjugated anti-paxillin (1:500; BD Transduction Laboratories) was used, after vinculin immunodetection. The actin cytoskeleton was stained using TRITC-conjugated phalloidin (1:1000; Chemicon). Blocking anti-integrin antibodies used were anti-&#x003b2;1 (mAb13; 10&#x000a0;&#x003bc;g/ml) and anti-&#x003b1;5 (mAb16; 25&#x000a0;&#x003bc;g/ml) both obtained from Dr K.M. Yamada (Fogerty et al., <xref ref-type="bibr" rid="B25">1990</xref>), anti-&#x003b1;9 [Y9A2; 10&#x000a0;&#x003bc;g/ml; originally obtained as a gift from Dr Dean Sheppard, Lung Biology Center, University of California San Francisco, San Francisco, CA, U.S.A. (Wang et al., <xref ref-type="bibr" rid="B58">1996</xref>) and then purchased from Abcam], anti-&#x003b1;v (mAb2021Z; 25&#x000a0;&#x003bc;g/ml; Chemicon), anti-&#x003b1;v&#x003b2;3 (LM609; 10&#x000a0;&#x003bc;g/ml; Biogenesis) and anti-&#x003b1;v&#x003b2;5 (P1F6; 5&#x000a0;&#x003bc;g/ml; Gibco BRL) antibodies. Mouse IgG (Sigma) was used as a negative control at a 10&#x000a0;&#x003bc;g/ml concentration. Y-27632 (Calbiochem), the specific inhibitor of ROCK, was used at a concentration of 20&#x000a0;&#x003bc;M.</p></sec><sec><title>Membrane fractionation</title><p>For the preparation of fractions enriched in plasma membrane proteins, HIEC cells were treated with ice-cold lysis buffer containing 250&#x000a0;mM sucrose, 10&#x000a0;mM Tris (pH&#x000a0;7.5), 1&#x000a0;mM PMSF and 1% protease inhibitor cocktail (Sigma). After three cycles of freeze-thaw, protein samples were centrifuged at 100000&#x000a0;<bold><italic>g</italic></bold> at 4&#x000b0;C for 1&#x000a0;h. The supernatant was removed and the pellet was washed twice with lysis buffer and resuspended in 100&#x000a0;&#x003bc;l of lysis buffer containing 0.1% SDS and 1% Triton X-100. The sample was centrifuged to clear cell debris (10000&#x000a0;<bold><italic>g</italic></bold> at 4&#x000b0;C for 20&#x000a0;min) and the supernatant was harvested and stored at &#x02013;20&#x000b0;C until used for Western-blot analyses.</p></sec><sec><title>RNA extraction and RT&#x02013;PCR</title><p>Total RNA, mRNA and cDNA were prepared as previously described (Dydensborg et al., <xref ref-type="bibr" rid="B20">2006</xref>). Single-stranded cDNA was amplified (Taq polymerase; New England Biolabs) for 30 cycles of denaturation (45&#x000a0;s at 94&#x000b0;C), annealing (45&#x000a0;s at 60&#x000b0;C) and extension (1&#x000a0;min at 72&#x000b0;C). For human &#x003b1;8 subunit detection, we used the forward primer 5&#x02032;-CAGTTTGGACGAATCCACCT-3&#x02032; and the reverse primer 5&#x02032;-TGCTGTCTGGATTGTCCTTG-3&#x02032;. Primer sequences for sucrase-isomaltase (oligo-1,6-glucosidase; EC 3.2.1.10), DPPIV and RPLP0 (ribosomal protein, large, P0) detection and the specific conditions used have been previously described (Dydensborg et al., <xref ref-type="bibr" rid="B20">2006</xref>; Escaffit et al., <xref ref-type="bibr" rid="B23">2006</xref>).</p></sec><sec><title>Western-blot analysis</title><p>Proteins were extracted, separated by SDS/PAGE and transferred on to nitrocellulose membranes as previously described (Perreault and Beaulieu, <xref ref-type="bibr" rid="B41">1996</xref>; Escaffit et al., <xref ref-type="bibr" rid="B21">2005a</xref>). For RhoA&#x02013;GTP pull-down assays, active RhoA was extracted using the Rho Activation Assay Biochem kit (Cytoskeleton) as previously described (Cetin et al., <xref ref-type="bibr" rid="B16">2007</xref>). Membranes were blocked in 5% (w/v) non-fat dried skimmed milk powder/PBS and 0.1% Tween 20 (Bio-Rad) and then incubated with primary antibodies overnight at 4&#x000b0;C. Primary antibodies were detected with horseradish peroxidase-conjugated secondary antibodies (anti-mouse and anti-rabbit; Amersham) and developed using the Immobilon Western&#x000ae; kit (Millipore).</p></sec><sec><title>Indirect immunofluorescence staining</title><p>The preparation and OCT (optimal cutting temperature; Canemco-Marivac, Lakefield, QC, Canada) embedding of specimens, cryosectioning as well as staining procedures were performed as previously described (Beaulieu et al., <xref ref-type="bibr" rid="B6">1992</xref>). HIEC cell immunofluorescence was done as previously described (Escaffit et al., <xref ref-type="bibr" rid="B22">2005b</xref>). Cells were seeded on to type&#x000a0;I collagen (BD Biosciences) or serum-pretreated coverslips (Fisher) 24&#x000a0;h before fixation. The secondary antibodies used were anti-mouse and anti-rabbit conjugated with FITC (Chemicon). For vinculin/paxillin co-immunolocalization, mouse IgG (Sigma) supplementary blocking and 2% (w/v) PFA (paraformaldehyde) post-fixation steps were found to be sufficient to block potential cross-reactions with FITC-conjugated anti-mouse. Nuclei were stained with DAPI (4&#x02032;,6-diamidino-2-phenylindole), whereas tissue sections were counterstained with 0.01% Evan Blue. Vinculin/paxillin-stained FXs were counted using the MetaMorph Imaging System (Universal Imaging, West Chester, PA, U.S.A.).</p></sec><sec><title>Cell adhesion assays</title><p>Adherent HIEC cells were harvested using PBS/0.5&#x000a0;mM EDTA (incubation for 10&#x000a0;min at 37&#x000b0;C) and centrifuged at 100&#x000a0;<bold><italic>g</italic></bold> for 5&#x000a0;min at 4&#x000b0;C. Cell pellets were resuspended in OptiMEM (Invitrogen) culture medium supplemented with 0.2% FBS (fetal bovine serum) and 0.3&#x000a0;mM MnCl<sub>2</sub>. For 24&#x000a0;h adhesion assays, cycloheximide was added to the medium at a concentration of 10&#x000a0;&#x003bc;g/ml throughout the assay to avoid endogenous ECM secretion (Vainionpaa et al., <xref ref-type="bibr" rid="B55">2006</xref>). However, for short-term adhesion assays, cycloheximide treatment was omitted since endogenous secretion was considered to be negligible. For assays involving blocking antibodies (short-term assays), suspensions of cells were incubated for 30&#x000a0;min at 37&#x000b0;C with the blocking antibody. Then, 48-well plates were treated with the appropriate coating (40&#x000a0;&#x003bc;g/ml of GST, GST&#x02013;TNfn3 RGD and GST&#x02013;TNfn3 RAA in PBS) and blocked with 2% (w/v) BSA. Cells were seeded (5&#x000d7;10<sup>4</sup> cells per well) and incubated for 1&#x000a0;h for short-term assays (with blocking antibodies) and 24&#x000a0;h for long-term assays (shRNA cells). Non-adherent cells were gently washed away with PBS and the remaining cells were fixed with 2% PFA (pH&#x000a0;7.4) for 1&#x000a0;h at 4&#x000b0;C and permeabilized with 0.1% Triton X-100. Cell nuclei were stained with DAPI and adherent cells were counted manually.</p></sec><sec><title>Cell migration assay</title><p>HIEC cells were seeded on to 100 mm<sup>2</sup> plates and cultured until 2&#x000a0;days post-confluence. Cell monolayers were wounded with a 19&#x000a0;mm plastic cell-scraper (Costar, Corning, NY, U.S.A.). Wounded cell monolayers were incubated for 48&#x000a0;h in OptiMEM with 2&#x000a0;mM hydroxyurea (Sigma) to block cell proliferation (Tetreault et al., <xref ref-type="bibr" rid="B50">2008</xref>). After incubation, DAPI staining was performed and the number of cells that had migrated across the wound edge was manually counted by immunofluorescent microscopy.</p></sec><sec><title>BrdU incorporation experiments</title><p>Each cell line was seeded on to serum-pretreated coverslips in a 24-well plate (Falcon) at 5&#x000d7;10<sup>4</sup> cells per well (and treated with Y-27632, where indicated), 24&#x000a0;h before the addition of BrdU labelling reagent (Roche). The procedure and reagents used for detection of S-phase positive HIEC cells were in accordance with the FLUOS&#x000ae; In Situ Cell Proliferation kit protocol (Roche).</p></sec><sec><title>Cell-cycle progression analysis by LSC</title><p>Each cell line was seeded on to a 12-well plate (Falcon) at 5&#x000d7;10<sup>4</sup> cells per well, 48&#x000a0;h before methanol fixation and DAPI staining. DAPI-stained cells were scanned with an iCys imaging cytometer (Compucyte, Cambridge, MA, U.S.A.) to measure DNA content using violet diode laser excitation (405&#x000a0;nm) and appropriate filters (463/39&#x000a0;nm) for fluorescence detection. DNA content was measured for at least 3000 isolated nuclei per sample in three separate experiments to assess cell-cycle distribution.</p></sec><sec><title>Statistical analysis</title><p>Results were expressed as means&#x000b1;S.E.M. Each experiment was repeated at least three times and representative results are shown. Values from adhesion assays and BrdU labelling experiments were subjected to the mixed linear model. All other values were subjected to the two-tailed Student's <italic>t</italic> test. <italic>P</italic>&#x0003c;0.05 was considered to be statistically significant.</p></sec></sec><sec sec-type="supplementary-material"><title>Online data</title><supplementary-material id="SD1" content-type="local-data" position="float" xlink:type="simple"><caption><title>Supplementary data</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="boc1010695add.pdf" position="float" xlink:type="simple"/></supplementary-material></sec></body><back><sec><title>Acknowledgements</title><p>We thank Dr Louis F. Reichardt, Dr Dean Sheppard, Dr Ga&#x000e9;tan Thibault and Dr Kenneth M. Yamada for the gift of antibodies. We also thank Marie-Pierre Garant and Aim&#x000e9; Ntwari for statistical analysis and Elizabeth Herring and Michael Dionne for valuable suggestions on the manuscript and technical support. Special thanks are due to Dominique Jean and Eric Tremblay for molecular cloning and virus production. LSC was performed at the Cell Imaging Facility located in the Service of Genetics of the Department of Pediatrics, Faculty of Medicine and Health Sciences, Universit&#x000e9; de Sherbrooke.</p></sec><sec><title>Funding</title><p>The Cell Imaging Facility is funded by grants from the <funding-source id="gs1">Canadian Foundation for Innovation</funding-source> and from the <funding-source id="gs2">Centre de recherche clinique &#x000c9;tienne Le Bel</funding-source> of the <funding-source id="gs3">Centre hospitalier universitaire de Sherbrooke (CHUS)</funding-source>. This work was supported by a grant from the <funding-source id="gs4">Canadian Institutes of Health Research</funding-source> [grant number <award-id rid="gs4">MOP-62914</award-id>]. J.-F.B. is the recipient of the <funding-source id="gs5">Canada Research Chair in Intestinal Physiopathology</funding-source> and is a member of the <funding-source id="gs6">Fonds de la recherche en sant&#x000e9; du Qu&#x000e9;bec (FRSQ)-funded Centre de Recherche Clinique &#x000c9;tienne Le Bel</funding-source> of the <funding-source id="gs7">Centre hospitalier universitaire de Sherbrooke (CHUS)</funding-source>.</p></sec><ref-list><ref id="B1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arsenault</surname><given-names>P.</given-names></name><name><surname>Menard</surname><given-names>D.</given-names></name></person-group><article-title>Cell proliferation during morphogenesis of the human colon</article-title><source>Biol. Neonate</source><year>1989</year><volume>55</volume><fpage>137</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">2742937</pub-id></element-citation></ref><ref id="B2"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Babyatsky</surname><given-names>M.W.</given-names></name><name><surname>Podolsky</surname><given-names>D.K.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Yamada</surname><given-names>T.</given-names></name></person-group><article-title>Growth and development of the gastrointestinal tract</article-title><source>Textbook of Gastroenterology</source><year>1999</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>J.B. Lippincott</publisher-name><fpage>547</fpage><lpage>584</lpage></element-citation></ref><ref id="B3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>S.T.</given-names></name><name><surname>Critchley</surname><given-names>D.R.</given-names></name></person-group><article-title>The RhoA-dependent assembly of focal adhesions in Swiss 3T3 cells is associated with increased tyrosine phosphorylation and the recruitment of both pp125FAK and protein kinase C-delta to focal adhesions</article-title><source>J. Cell Sci.</source><year>1994</year><volume>107</volume><fpage>2033</fpage><lpage>2045</lpage><pub-id pub-id-type="pmid">7527052</pub-id></element-citation></ref><ref id="B4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basora</surname><given-names>N.</given-names></name><name><surname>Vachon</surname><given-names>P.H.</given-names></name><name><surname>Herring-Gillam</surname><given-names>F.E.</given-names></name><name><surname>Perreault</surname><given-names>N.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Relation between integrin alpha7Bbeta1 expression in human intestinal cells and enterocytic differentiation</article-title><source>Gastroenterology</source><year>1997</year><volume>113</volume><fpage>1510</fpage><lpage>1521</lpage><pub-id pub-id-type="pmid">9352853</pub-id></element-citation></ref><ref id="B5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Extracellular matrix components and integrins in relationship to human intestinal epithelial cell differentiation</article-title><source>Prog. Histochem. Cytochem.</source><year>1997</year><volume>31</volume><fpage>1</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">9088045</pub-id></element-citation></ref><ref id="B7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Integrins and human intestinal cell functions</article-title><source>Front. Biosci.</source><year>1999</year><volume>4</volume><fpage>D310</fpage><lpage>D321</lpage><pub-id pub-id-type="pmid">10077538</pub-id></element-citation></ref><ref id="B8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name><name><surname>Quaroni</surname><given-names>A.</given-names></name></person-group><article-title>Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells</article-title><source>Biochem. J.</source><year>1991</year><volume>280</volume><fpage>599</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">1764023</pub-id></element-citation></ref><ref id="B6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name><name><surname>Millane</surname><given-names>G.</given-names></name><name><surname>Calvert</surname><given-names>R.</given-names></name></person-group><article-title>Developmental expression of two antigens associated with mouse intestinal crypts</article-title><source>Dev. Dyn.</source><year>1992</year><volume>193</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">1511172</pub-id></element-citation></ref><ref id="B9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name><name><surname>Jutras</surname><given-names>S.</given-names></name><name><surname>Durand</surname><given-names>J.</given-names></name><name><surname>Vachon</surname><given-names>P.H.</given-names></name><name><surname>Perreault</surname><given-names>N.</given-names></name></person-group><article-title>Relationship between tenascin and alpha-smooth muscle actin expression in the developing human small intestinal mucosa</article-title><source>Anat. Embryol.</source><year>1993</year><volume>188</volume><fpage>149</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">7692766</pub-id></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bershadsky</surname><given-names>A.</given-names></name><name><surname>Kozlov</surname><given-names>M.</given-names></name><name><surname>Geiger</surname><given-names>B.</given-names></name></person-group><article-title>Adhesion-mediated mechanosensitivity: a time to experiment, and a time to theorize</article-title><source>Curr. Opin. Cell Biol.</source><year>2006</year><volume>18</volume><fpage>472</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">16930976</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieritz</surname><given-names>B.</given-names></name><name><surname>Spessotto</surname><given-names>P.</given-names></name><name><surname>Colombatti</surname><given-names>A.</given-names></name><name><surname>Jahn</surname><given-names>A.</given-names></name><name><surname>Prols</surname><given-names>F.</given-names></name><name><surname>Hartner</surname><given-names>A.</given-names></name></person-group><article-title>Role of alpha8 integrin in mesangial cell adhesion, migration, and proliferation</article-title><source>Kidney Int.</source><year>2003</year><volume>64</volume><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">12787402</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosse</surname><given-names>T.</given-names></name><name><surname>Fialkovich</surname><given-names>J.J.</given-names></name><name><surname>Piaseckyj</surname><given-names>C.M.</given-names></name><name><surname>Beuling</surname><given-names>E.</given-names></name><name><surname>Broekman</surname><given-names>H.</given-names></name><name><surname>Grand</surname><given-names>R.J.</given-names></name><name><surname>Montgomery</surname><given-names>R.K.</given-names></name><name><surname>Krasinski</surname><given-names>S.D.</given-names></name></person-group><article-title>Gata4 and Hnf1alpha are partially required for the expression of specific intestinal genes during development</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2007</year><volume>292</volume><fpage>G1302</fpage><lpage>G1314</lpage><pub-id pub-id-type="pmid">17272516</pub-id></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bossy</surname><given-names>B.</given-names></name><name><surname>Bossy-Wetzel</surname><given-names>E.</given-names></name><name><surname>Reichardt</surname><given-names>L.F.</given-names></name></person-group><article-title>Characterization of the integrin alpha 8 subunit: a new integrin beta 1-associated subunit, which is prominently expressed on axons and on cells in contact with basal laminae in chick embryos</article-title><source>EMBO J.</source><year>1991</year><volume>10</volume><fpage>2375</fpage><lpage>2385</lpage><pub-id pub-id-type="pmid">1714374</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudreau</surname><given-names>F.</given-names></name><name><surname>Lussier</surname><given-names>C.R.</given-names></name><name><surname>Mongrain</surname><given-names>S.</given-names></name><name><surname>Darsigny</surname><given-names>M.</given-names></name><name><surname>Drouin</surname><given-names>J.L.</given-names></name><name><surname>Doyon</surname><given-names>G.</given-names></name><name><surname>Suh</surname><given-names>E.R.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name><name><surname>Rivard</surname><given-names>N.</given-names></name><name><surname>Perreault</surname><given-names>N.</given-names></name></person-group><article-title>Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia</article-title><source>FASEB J.</source><year>2007</year><volume>21</volume><fpage>3853</fpage><lpage>3865</lpage><pub-id pub-id-type="pmid">17622569</pub-id></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cetin</surname><given-names>S.</given-names></name><name><surname>Ford</surname><given-names>H.R.</given-names></name><name><surname>Sysko</surname><given-names>L.R.</given-names></name><name><surname>Agarwal</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Neal</surname><given-names>M.D.</given-names></name><name><surname>Baty</surname><given-names>C.</given-names></name><name><surname>Apodaca</surname><given-names>G.</given-names></name><name><surname>Hackam</surname><given-names>D.J.</given-names></name></person-group><article-title>Endotoxin inhibits intestinal epithelial restitution through activation of Rho-GTPase and increased focal adhesions</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>24592</fpage><lpage>24600</lpage><pub-id pub-id-type="pmid">15169791</pub-id></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cetin</surname><given-names>S.</given-names></name><name><surname>Leaphart</surname><given-names>C.L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Ischenko</surname><given-names>I.</given-names></name><name><surname>Hayman</surname><given-names>M.</given-names></name><name><surname>Upperman</surname><given-names>J.</given-names></name><name><surname>Zamora</surname><given-names>R.</given-names></name><name><surname>Watkins</surname><given-names>S.</given-names></name><name><surname>Ford</surname><given-names>H.R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hackam</surname><given-names>D.J.</given-names></name></person-group><article-title>Nitric oxide inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2-dependent manner</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2007</year><volume>292</volume><fpage>G1347</fpage><lpage>G1358</lpage><pub-id pub-id-type="pmid">17272518</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>E.A.</given-names></name><name><surname>Brugge</surname><given-names>J.S.</given-names></name></person-group><article-title>Integrins and signal transduction pathways: the road taken</article-title><source>Science</source><year>1995</year><volume>268</volume><fpage>233</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">7716514</pub-id></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croft</surname><given-names>D.R.</given-names></name><name><surname>Olson</surname><given-names>M.F.</given-names></name></person-group><article-title>The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms</article-title><source>Mol. Cell. Biol.</source><year>2006</year><volume>26</volume><fpage>4612</fpage><lpage>4627</lpage><pub-id pub-id-type="pmid">16738326</pub-id></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desloges</surname><given-names>N.</given-names></name><name><surname>Basora</surname><given-names>N.</given-names></name><name><surname>Perreault</surname><given-names>N.</given-names></name><name><surname>Bouatrouss</surname><given-names>Y.</given-names></name><name><surname>Sheppard</surname><given-names>D.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Regulated expression of the integrin alpha9beta1 in the epithelium of the developing human gut and in intestinal cell lines: relation with cell proliferation</article-title><source>J. Cell Biochem.</source><year>1998</year><volume>71</volume><fpage>536</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">9827699</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dydensborg</surname><given-names>A.B.</given-names></name><name><surname>Herring</surname><given-names>E.</given-names></name><name><surname>Auclair</surname><given-names>J.</given-names></name><name><surname>Tremblay</surname><given-names>E.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Normalizing genes for quantitative RT&#x02013;PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2006</year><volume>290</volume><fpage>G1067</fpage><lpage>G1074</lpage><pub-id pub-id-type="pmid">16399877</pub-id></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escaffit</surname><given-names>F.</given-names></name><name><surname>Boudreau</surname><given-names>F.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Differential expression of claudin-2 along the human intestine: Implication of GATA-4 in the maintenance of claudin-2 in differentiating cells</article-title><source>J. Cell Physiol.</source><year>2005a</year><volume>203</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">15389642</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escaffit</surname><given-names>F.</given-names></name><name><surname>Perreault</surname><given-names>N.</given-names></name><name><surname>Jean</surname><given-names>D.</given-names></name><name><surname>Francoeur</surname><given-names>C.</given-names></name><name><surname>Herring</surname><given-names>E.</given-names></name><name><surname>Rancourt</surname><given-names>C.</given-names></name><name><surname>Rivard</surname><given-names>N.</given-names></name><name><surname>Vachon</surname><given-names>P.H.</given-names></name><name><surname>Pare</surname><given-names>F.</given-names></name><name><surname>Boucher</surname><given-names>M.P.</given-names></name><etal/></person-group><article-title>Repressed E-cadherin expression in the lower crypt of human small intestine: a cell marker of functional relevance</article-title><source>Exp. Cell Res.</source><year>2005b</year><volume>302</volume><fpage>206</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">15561102</pub-id></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escaffit</surname><given-names>F.</given-names></name><name><surname>Pare</surname><given-names>F.</given-names></name><name><surname>Gauthier</surname><given-names>R.</given-names></name><name><surname>Rivard</surname><given-names>N.</given-names></name><name><surname>Boudreau</surname><given-names>F.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Cdx2 modulates proliferation in normal human intestinal epithelial crypt cells</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2006</year><volume>342</volume><fpage>66</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">16480684</pub-id></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farias</surname><given-names>E.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Schnapp</surname><given-names>L.M.</given-names></name></person-group><article-title>Integrin alpha8beta1-fibronectin interactions promote cell survival via PI3 kinase pathway</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2005</year><volume>329</volume><fpage>305</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">15721307</pub-id></element-citation></ref><ref id="B25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogerty</surname><given-names>F.J.</given-names></name><name><surname>Akiyama</surname><given-names>S.K.</given-names></name><name><surname>Yamada</surname><given-names>K.M.</given-names></name><name><surname>Mosher</surname><given-names>D.F.</given-names></name></person-group><article-title>Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies</article-title><source>J. Cell Biol.</source><year>1990</year><volume>111</volume><fpage>699</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">2380248</pub-id></element-citation></ref><ref id="B26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname><given-names>B.</given-names></name><name><surname>Bershadsky</surname><given-names>A.</given-names></name></person-group><article-title>Assembly and mechanosensory function of focal contacts</article-title><source>Curr. Opin. Cell Biol.</source><year>2001</year><volume>13</volume><fpage>584</fpage><lpage>592</lpage><pub-id pub-id-type="pmid">11544027</pub-id></element-citation></ref><ref id="B27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giancotti</surname><given-names>F.G.</given-names></name></person-group><article-title>Integrin signaling: specificity and control of cell survival and cell cycle progression</article-title><source>Curr. Opin. Cell Biol.</source><year>1997</year><volume>9</volume><fpage>691</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">9330873</pub-id></element-citation></ref><ref id="B28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gout</surname><given-names>S.P.</given-names></name><name><surname>Jacquier-Sarlin</surname><given-names>M.R.</given-names></name><name><surname>Rouard-Talbot</surname><given-names>L.</given-names></name><name><surname>Rousselle</surname><given-names>P.</given-names></name><name><surname>Block</surname><given-names>M.R.</given-names></name></person-group><article-title>RhoA-dependent switch between alpha2beta1 and alpha3beta1 integrins is induced by laminin-5 during early stage of HT-29 cell differentiation</article-title><source>Mol. Biol. Cell</source><year>2001</year><volume>12</volume><fpage>3268</fpage><lpage>3281</lpage><pub-id pub-id-type="pmid">11598208</pub-id></element-citation></ref><ref id="B29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jobin</surname><given-names>C.</given-names></name><name><surname>Behrns</surname><given-names>K.E.</given-names></name><name><surname>Brenner</surname><given-names>D.A.</given-names></name></person-group><article-title>Molecular and cellular biology of the small intestine</article-title><source>Curr. Opin. Gastroenterol.</source><year>1999</year><volume>15</volume><fpage>103</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">17023928</pub-id></element-citation></ref><ref id="B30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>J.M.</given-names></name><name><surname>Hsieh</surname><given-names>C.L.</given-names></name><name><surname>Chang</surname><given-names>Z.F.</given-names></name></person-group><article-title>Caspase activation during phorbol ester-induced apoptosis requires ROCK-dependent myosin-mediated contraction</article-title><source>J. Cell Sci.</source><year>2003</year><volume>116</volume><fpage>3491</fpage><lpage>3501</lpage><pub-id pub-id-type="pmid">12865435</pub-id></element-citation></ref><ref id="B31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>D.</given-names></name><name><surname>Rockey</surname><given-names>D.C.</given-names></name><name><surname>Milner</surname><given-names>T.A.</given-names></name><name><surname>Breuss</surname><given-names>J.M.</given-names></name><name><surname>Fallon</surname><given-names>J.T.</given-names></name><name><surname>Schnapp</surname><given-names>L.M.</given-names></name></person-group><article-title>Expression of the integrin alpha8beta1 during pulmonary and hepatic fibrosis</article-title><source>Am. J. Pathol.</source><year>2000</year><volume>156</volume><fpage>1927</fpage><lpage>1935</lpage><pub-id pub-id-type="pmid">10854216</pub-id></element-citation></ref><ref id="B32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lock</surname><given-names>J.G.</given-names></name><name><surname>Wehrle-Haller</surname><given-names>B.</given-names></name><name><surname>Stromblad</surname><given-names>S.</given-names></name></person-group><article-title>Cell-matrix adhesion complexes: master control machinery of cell migration</article-title><source>Semin. Cancer Biol.</source><year>2008</year><volume>18</volume><fpage>65</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">18023204</pub-id></element-citation></ref><ref id="B33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loirand</surname><given-names>G.</given-names></name><name><surname>Guerin</surname><given-names>P.</given-names></name><name><surname>Pacaud</surname><given-names>P.</given-names></name></person-group><article-title>Rho kinases in cardiovascular physiology and pathophysiology</article-title><source>Circ. Res.</source><year>2006</year><volume>98</volume><fpage>322</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">16484628</pub-id></element-citation></ref><ref id="B34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Munger</surname><given-names>J.S.</given-names></name><name><surname>Steadele</surname><given-names>M.</given-names></name><name><surname>Busald</surname><given-names>C.</given-names></name><name><surname>Tellier</surname><given-names>M.</given-names></name><name><surname>Schnapp</surname><given-names>L.M.</given-names></name></person-group><article-title>Integrin alpha8beta1 mediates adhesion to LAP-TGFbeta1</article-title><source>J. Cell Sci.</source><year>2002</year><volume>115</volume><fpage>4641</fpage><lpage>4648</lpage><pub-id pub-id-type="pmid">12415008</pub-id></element-citation></ref><ref id="B35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lussier</surname><given-names>C.</given-names></name><name><surname>Basora</surname><given-names>N.</given-names></name><name><surname>Bouatrouss</surname><given-names>Y.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Integrins as mediators of epithelial cell-matrix interactions in the human small intestinal mucosa</article-title><source>Microsc. Res. Tech.</source><year>2000</year><volume>51</volume><fpage>169</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">11054867</pub-id></element-citation></ref><ref id="B36"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>M&#x000e9;nard</surname><given-names>D.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Bkaily</surname><given-names>G.</given-names></name></person-group><article-title>Human intestinal brush border membrane hydrolases</article-title><source>Membrane Physiopathology</source><year>1994</year><publisher-name>Kluwer Academic</publisher-name><fpage>319</fpage><lpage>341</lpage></element-citation></ref><ref id="B37"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>M&#x000e9;nard</surname><given-names>D.</given-names></name><name><surname>Beaulieu</surname><given-names>J.-F.</given-names></name><name><surname>Boudreau</surname><given-names>F.</given-names></name><name><surname>Perreault</surname><given-names>N.</given-names></name><name><surname>Rivard</surname><given-names>N.</given-names></name><name><surname>Vachon</surname><given-names>P.H.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Krieglstein</surname><given-names>K.</given-names></name><name><surname>Unsicker</surname><given-names>K.</given-names></name></person-group><article-title>Gastrointestinal tract</article-title><source>Cell Signaling and Growth Factors in Development: From Molecules to Organogenesis, volume 2</source><year>2006</year><publisher-name>Wiley-VCH</publisher-name><fpage>755</fpage><lpage>790</lpage></element-citation></ref><ref id="B38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercurio</surname><given-names>A.M.</given-names></name></person-group><article-title>Laminin receptors: achieving specificity through cooperation</article-title><source>Trends Cell Biol.</source><year>1995</year><volume>5</volume><fpage>419</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">14732046</pub-id></element-citation></ref><ref id="B39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>U.</given-names></name><name><surname>Bossy</surname><given-names>B.</given-names></name><name><surname>Venstrom</surname><given-names>K.</given-names></name><name><surname>Reichardt</surname><given-names>L.F.</given-names></name></person-group><article-title>Integrin alpha 8 beta 1 promotes attachment, cell spreading, and neurite outgrowth on fibronectin</article-title><source>Mol. Biol. Cell</source><year>1995</year><volume>6</volume><fpage>433</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">7626807</pub-id></element-citation></ref><ref id="B40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pageot</surname><given-names>L.P.</given-names></name><name><surname>Perreault</surname><given-names>N.</given-names></name><name><surname>Basora</surname><given-names>N.</given-names></name><name><surname>Francoeur</surname><given-names>C.</given-names></name><name><surname>Magny</surname><given-names>P.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Human cell models to study small intestinal functions: recapitulation of the crypt&#x02013;villus axis</article-title><source>Microsc. Res. Tech.</source><year>2000</year><volume>49</volume><fpage>394</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">10820523</pub-id></element-citation></ref><ref id="B41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perreault</surname><given-names>N.</given-names></name><name><surname>Beaulieu</surname><given-names>J.</given-names></name></person-group><article-title>Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures</article-title><source>Exp. Cell Res.</source><year>1996</year><volume>224</volume><fpage>354</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">8612712</pub-id></element-citation></ref><ref id="B42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perreault</surname><given-names>N.</given-names></name><name><surname>Herring-Gillam</surname><given-names>F.E.</given-names></name><name><surname>Desloges</surname><given-names>N.</given-names></name><name><surname>Belanger</surname><given-names>I.</given-names></name><name><surname>Pageot</surname><given-names>L.P.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Epithelial vs mesenchymal contribution to the extracellular matrix in the human intestine</article-title><source>Biochem Biophys. Res. Commun.</source><year>1998</year><volume>248</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">9675097</pub-id></element-citation></ref><ref id="B43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quaroni</surname><given-names>A.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Cell dynamics and differentiation of conditionally immortalized human intestinal epithelial cells</article-title><source>Gastroenterology</source><year>1997</year><volume>113</volume><fpage>1198</fpage><lpage>1213</lpage><pub-id pub-id-type="pmid">9322515</pub-id></element-citation></ref><ref id="B44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddig</surname><given-names>P.J.</given-names></name><name><surname>Juliano</surname><given-names>R.L.</given-names></name></person-group><article-title>Clinging to life: cell to matrix adhesion and cell survival</article-title><source>Cancer Metastasis Rev.</source><year>2005</year><volume>24</volume><fpage>425</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">16258730</pub-id></element-citation></ref><ref id="B45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>J.M.</given-names></name><name><surname>Florian</surname><given-names>P.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Graham</surname><given-names>W.V.</given-names></name><name><surname>Tretiakova</surname><given-names>M.S.</given-names></name><name><surname>Gitter</surname><given-names>A.H.</given-names></name><name><surname>Mrsny</surname><given-names>R.J.</given-names></name><name><surname>Turner</surname><given-names>J.R.</given-names></name></person-group><article-title>Distinct temporal-spatial roles for Rho kinase and myosin light chain kinase in epithelial purse-string wound closure</article-title><source>Gastroenterology</source><year>2005</year><volume>128</volume><fpage>987</fpage><lpage>1001</lpage><pub-id pub-id-type="pmid">15825080</pub-id></element-citation></ref><ref id="B46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnapp</surname><given-names>L.M.</given-names></name><name><surname>Breuss</surname><given-names>J.M.</given-names></name><name><surname>Ramos</surname><given-names>D.M.</given-names></name><name><surname>Sheppard</surname><given-names>D.</given-names></name><name><surname>Pytela</surname><given-names>R.</given-names></name></person-group><article-title>Sequence and tissue distribution of the human integrin alpha 8 subunit: a beta 1-associated alpha subunit expressed in smooth muscle cells</article-title><source>J. Cell Sci.</source><year>1995a</year><volume>108</volume><fpage>537</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">7768999</pub-id></element-citation></ref><ref id="B47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnapp</surname><given-names>L.M.</given-names></name><name><surname>Hatch</surname><given-names>N.</given-names></name><name><surname>Ramos</surname><given-names>D.M.</given-names></name><name><surname>Klimanskaya</surname><given-names>I.V.</given-names></name><name><surname>Sheppard</surname><given-names>D.</given-names></name><name><surname>Pytela</surname><given-names>R.</given-names></name></person-group><article-title>The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin</article-title><source>J. Biol. Chem.</source><year>1995b</year><volume>270</volume><fpage>23196</fpage><lpage>23202</lpage><pub-id pub-id-type="pmid">7559467</pub-id></element-citation></ref><ref id="B48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheppard</surname><given-names>D.</given-names></name></person-group><article-title>Epithelial integrins</article-title><source>BioEssays</source><year>1996</year><volume>18</volume><fpage>655</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">8760339</pub-id></element-citation></ref><ref id="B49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>L.L.</given-names></name><name><surname>Cheung</surname><given-names>H.K.</given-names></name><name><surname>Ling</surname><given-names>L.E.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Sheppard</surname><given-names>D.</given-names></name><name><surname>Pytela</surname><given-names>R.</given-names></name><name><surname>Giachelli</surname><given-names>C.M.</given-names></name></person-group><article-title>Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin</article-title><source>J. Biol. Chem.</source><year>1996</year><volume>271</volume><fpage>28485</fpage><lpage>28491</lpage><pub-id pub-id-type="pmid">8910476</pub-id></element-citation></ref><ref id="B50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tetreault</surname><given-names>M.P.</given-names></name><name><surname>Chailler</surname><given-names>P.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name><name><surname>Rivard</surname><given-names>N.</given-names></name><name><surname>Menard</surname><given-names>D.</given-names></name></person-group><article-title>Epidermal growth factor receptor-dependent PI3K-activation promotes restitution of wounded human gastric epithelial monolayers</article-title><source>J. Cell Physiol.</source><year>2008</year><volume>214</volume><fpage>545</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">17708540</pub-id></element-citation></ref><ref id="B51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>E.</given-names></name><name><surname>Auclair</surname><given-names>J.</given-names></name><name><surname>Delvin</surname><given-names>E.</given-names></name><name><surname>Levy</surname><given-names>E.</given-names></name><name><surname>Menard</surname><given-names>D.</given-names></name><name><surname>Pshezhetsky</surname><given-names>A.V.</given-names></name><name><surname>Rivard</surname><given-names>N.</given-names></name><name><surname>Seidman</surname><given-names>E.G.</given-names></name><name><surname>Sinnett</surname><given-names>D.</given-names></name><name><surname>Vachon</surname><given-names>P.H.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Gene expression profiles of normal proliferating and differentiating human intestinal epithelial cells: a comparison with the Caco-2 cell model</article-title><source>J. Cell. Biochem.</source><year>2006</year><volume>99</volume><fpage>1175</fpage><lpage>1186</lpage><pub-id pub-id-type="pmid">16795037</pub-id></element-citation></ref><ref id="B52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>C.E.</given-names></name></person-group><article-title>Paxillin and focal adhesion signalling</article-title><source>Nat. Cell Biol.</source><year>2000</year><volume>2</volume><fpage>E231</fpage><lpage>E236</lpage><pub-id pub-id-type="pmid">11146675</pub-id></element-citation></ref><ref id="B53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vachon</surname><given-names>P.H.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line</article-title><source>Gastroenterology</source><year>1992</year><volume>103</volume><fpage>414</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">1634060</pub-id></element-citation></ref><ref id="B54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vachon</surname><given-names>P.H.</given-names></name><name><surname>Simoneau</surname><given-names>A.</given-names></name><name><surname>Herring-Gillam</surname><given-names>F.E.</given-names></name><name><surname>Beaulieu</surname><given-names>J.F.</given-names></name></person-group><article-title>Cellular fibronectin expression is down-regulated at the mRNA level in differentiating human intestinal epithelial cells</article-title><source>Exp. Cell Res.</source><year>1995</year><volume>216</volume><fpage>30</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">7813630</pub-id></element-citation></ref><ref id="B55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vainionpaa</surname><given-names>N.</given-names></name><name><surname>Kikkawa</surname><given-names>Y.</given-names></name><name><surname>Lounatmaa</surname><given-names>K.</given-names></name><name><surname>Miner</surname><given-names>J.H.</given-names></name><name><surname>Rousselle</surname><given-names>P.</given-names></name><name><surname>Virtanen</surname><given-names>I.</given-names></name></person-group><article-title>Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2006</year><volume>290</volume><fpage>C764</fpage><lpage>C775</lpage><pub-id pub-id-type="pmid">16236823</pub-id></element-citation></ref><ref id="B56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>T.E.</given-names></name><name><surname>Frevert</surname><given-names>C.W.</given-names></name><name><surname>Herzog</surname><given-names>E.L.</given-names></name><name><surname>Schnapp</surname><given-names>L.M.</given-names></name></person-group><article-title>Expression of the integrin subunit alpha8 in murine lung development</article-title><source>J. Histochem. Cytochem.</source><year>2003</year><volume>51</volume><fpage>1307</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">14500699</pub-id></element-citation></ref><ref id="B57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>J.L.</given-names></name><name><surname>Assoian</surname><given-names>R.K.</given-names></name></person-group><article-title>Integrin-dependent signal transduction regulating cyclin D1 expression and G<sub>1</sub> phase cell cycle progression</article-title><source>Cancer Metastasis Rev.</source><year>2005</year><volume>24</volume><fpage>383</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">16258726</pub-id></element-citation></ref><ref id="B58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A.</given-names></name><name><surname>Yokosaki</surname><given-names>Y.</given-names></name><name><surname>Ferrando</surname><given-names>R.</given-names></name><name><surname>Balmes</surname><given-names>J.</given-names></name><name><surname>Sheppard</surname><given-names>D.</given-names></name></person-group><article-title>Differential regulation of airway epithelial integrins by growth factors</article-title><source>Am. J. Respir. Cell Mol. Biol.</source><year>1996</year><volume>15</volume><fpage>664</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">8918373</pub-id></element-citation></ref><ref id="B59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokosaki</surname><given-names>Y.</given-names></name><name><surname>Matsuura</surname><given-names>N.</given-names></name><name><surname>Higashiyama</surname><given-names>S.</given-names></name><name><surname>Murakami</surname><given-names>I.</given-names></name><name><surname>Obara</surname><given-names>M.</given-names></name><name><surname>Yamakido</surname><given-names>M.</given-names></name><name><surname>Shigeto</surname><given-names>N.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Sheppard</surname><given-names>D.</given-names></name></person-group><article-title>Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin typeIII repeat of tenascin-C</article-title><source>J. Biol. Chem.</source><year>1998</year><volume>273</volume><fpage>11423</fpage><lpage>11428</lpage><pub-id pub-id-type="pmid">9565552</pub-id></element-citation></ref><ref id="B60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaidel-Bar</surname><given-names>R.</given-names></name><name><surname>Ballestrem</surname><given-names>C.</given-names></name><name><surname>Kam</surname><given-names>Z.</given-names></name><name><surname>Geiger</surname><given-names>B.</given-names></name></person-group><article-title>Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells</article-title><source>J. Cell Sci.</source><year>2003</year><volume>116</volume><fpage>4605</fpage><lpage>4613</lpage><pub-id pub-id-type="pmid">14576354</pub-id></element-citation></ref><ref id="B61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaidel-Bar</surname><given-names>R.</given-names></name><name><surname>Cohen</surname><given-names>M.</given-names></name><name><surname>Addadi</surname><given-names>L.</given-names></name><name><surname>Geiger</surname><given-names>B.</given-names></name></person-group><article-title>Hierarchical assembly of cell-matrix adhesion complexes</article-title><source>Biochem. Soc. Trans.</source><year>2004</year><volume>32</volume><fpage>416</fpage><lpage>420</lpage><pub-id pub-id-type="pmid">15157150</pub-id></element-citation></ref><ref id="B62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zargham</surname><given-names>R.</given-names></name><name><surname>Thibault</surname><given-names>G.</given-names></name></person-group><article-title>alpha8beta1 Integrin expression in the rat carotid artery: involvement in smooth muscle cell migration and neointima formation</article-title><source>Cardiovasc. Res.</source><year>2005</year><volume>65</volume><fpage>813</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">15721861</pub-id></element-citation></ref><ref id="B63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zargham</surname><given-names>R.</given-names></name><name><surname>Thibault</surname><given-names>G.</given-names></name></person-group><article-title>Alpha 8 integrin expression is required for maintenance of the smooth muscle cell differentiated phenotype</article-title><source>Cardiovasc. Res.</source><year>2006</year><volume>71</volume><fpage>170</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">16603140</pub-id></element-citation></ref><ref id="B64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zargham</surname><given-names>R.</given-names></name><name><surname>Wamhoff</surname><given-names>B.R.</given-names></name><name><surname>Thibault</surname><given-names>G.</given-names></name></person-group><article-title>RNA interference targeting alpha8 integrin attenuates smooth muscle cell growth</article-title><source>FEBS Lett.</source><year>2007a</year><volume>581</volume><fpage>939</fpage><lpage>943</lpage><pub-id pub-id-type="pmid">17300786</pub-id></element-citation></ref><ref id="B65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zargham</surname><given-names>R.</given-names></name><name><surname>Touyz</surname><given-names>R.M.</given-names></name><name><surname>Thibault</surname><given-names>G.</given-names></name></person-group><article-title>alpha 8 Integrin overexpression in de-differentiated vascular smooth muscle cells attenuates migratory activity and restores the characteristics of the differentiated phenotype</article-title><source>Atherosclerosis</source><year>2007b</year><volume>195</volume><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">17275006</pub-id></element-citation></ref><ref id="B66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Sanders</surname><given-names>M.A.</given-names></name><name><surname>Sumpio</surname><given-names>B.E.</given-names></name><name><surname>Panja</surname><given-names>A.</given-names></name><name><surname>Basson</surname><given-names>M.D.</given-names></name></person-group><article-title>Regulation of the intestinal epithelial response to cyclic strain by extracellular matrix proteins</article-title><source>FASEB J.</source><year>2003</year><volume>17</volume><fpage>926</fpage><lpage>928</lpage><pub-id pub-id-type="pmid">12626437</pub-id></element-citation></ref><ref id="B67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimerman</surname><given-names>B.</given-names></name><name><surname>Volberg</surname><given-names>T.</given-names></name><name><surname>Geiger</surname><given-names>B.</given-names></name></person-group><article-title>Early molecular events in the assembly of the focal adhesion-stress fibre complex during fibroblast spreading</article-title><source>Cell Motil. Cytoskeleton</source><year>2004</year><volume>58</volume><fpage>143</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">15146534</pub-id></element-citation></ref></ref-list></back></article>